Delisting riskPopularity #4,280
ARTL · NASDAQ · Biotechnology

Artelo Biosciences (ARTL)

Develops cannabinoid and fatty-acid-binding-protein drug candidates for cancer supportive care and pain.

$4.11
After-hours close−0.06 (−1.53%)
At close$4.18(+1.83%)